Vitamins and stroke - The homocysteine hypothesis still in doubt

被引:18
作者
Ntaios, George C. [1 ]
Savopoulos, Christos G. [1 ]
Chatzinikolaou, Anastasia C. [1 ]
Kaiafa, Georgia D. [1 ]
Hatzitolios, Apostolos [1 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Hosp, Med Propedeut Dept 1, Thessaloniki 54636, Greece
关键词
homocysteine; folate; cIMT; cardiovascular risk;
D O I
10.1097/01.nrl.0000253066.85963.aa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
During the last years, many epidemiologic studies have identified homocysteine as an independent risk factor for cardiovascular diseases like coronary events, stroke, and venous thromboembolism. Supplementation with oral folate and vitamins B6 and B12 (mainly folate) reduce plasma homocysteine levels to a significant degree. Recent clinical trials showed that vitamin supplementation leads to slower progression or even regression of atherosclerotic lesions in the carotid arteries, as confirmed by ultrasonographic measurement of carotid intima media thickness. However, the recent Vitamin Intervention for Stroke Prevention (VISP) study failed to show any clinical effect on stroke prevention. It is unclear if homocysteine-lowering therapy really has a role in the prevention of cardiovascular diseases. Large trials, which are already conducted, will probably give the definitive answer. In this review, we try to keep pace with the data that make the homocysteine hypothesis still doubtful.
引用
收藏
页码:2 / 4
页数:3
相关论文
共 24 条
[1]   Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes [J].
Al-Obaidi, MK ;
Stubbs, PJ ;
Collinson, P ;
Conroy, R ;
Graham, I ;
Noble, MIM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1217-1222
[2]  
[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A
[3]  
*BET VIT TREATM TR, 2006, AM HEART J, V151, P282
[4]   Power shortage: Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour [J].
Bostom, AG ;
Selhub, J ;
Jacques, PF ;
Rosenberg, IH .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (02) :133-139
[5]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[6]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[7]   Reevaluating the benefits of folic acid fortification in the United States: Economic analysis, regulation, and public health [J].
Grosse, SD ;
Waitzman, NJ ;
Romano, PS ;
Mulinare, J .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2005, 95 (11) :1917-1922
[8]   The effect of folic acid fortification on plasma folate and total homocysteine concentrations [J].
Jacques, PF ;
Selhub, J ;
Bostom, AG ;
Wilson, PWF ;
Rosenberg, IH .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (19) :1449-1454
[9]   Homocyst(e)ine, diet, and cardiovascular diseases - A statement for healthcare professionals from the Nutrition Committee, American Heart Association [J].
Malinow, MR ;
Bostom, AG ;
Krauss, RM .
CIRCULATION, 1999, 99 (01) :178-182
[10]   Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients [J].
Marcucci, R ;
Zanazzi, M ;
Bertoni, E ;
Rosati, A ;
Fedi, S ;
Lenti, M ;
Prisco, D ;
Castellani, S ;
Abbate, R ;
Salvadori, M .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) :2491-2492